Literature DB >> 32571002

The Relationship between Neuropsychiatric Symptoms and Default-Mode Network Connectivity in Alzheimer's Disease.

Jung Suk Lee1,2, Jong Hun Kim1,3, Seon-Koo Lee4.   

Abstract

OBJECTIVE: Neuropsychiatric symptoms of dementia are prevalent and extremely burdening for the patient and caregivers, but the underlying mechanism of these symptoms has not been investigated. This study aimed to investigate the relationship between neuropsychiatric symptoms and default-mode functional connectivity in Alzheimer's disease.
METHODS: Neuropsychiatric symptoms were assessed using the Neuropsychiatric Inventory. Functional magnetic resonance imaging was conducted on seventy patients with Alzheimer's disease during rest. We conducted a seed-based functional connectivity analysis to identify anterior and posterior default-mode networks (DMN). Seeds were the medial prefrontal cortex (Montreal Neurological Institute 12, 51, 36; seed radius=3 mm) for the anterior DMN and the precuneus (Montreal Neurological Institute -6, -63, 27; seed radius=3 mm) for the posterior DMN We then correlated the scores on neuropsychiatric inventory syndromes (apathy, hyperactivity, affective, and psychosis syndrome) with maps of connectivity in the default-mode network.
RESULTS: There was a significant correlation between decreased connectivity in the medial prefrontal cortex of the anterior defaultmode network and hyperactivity (agitation, irritability, aberrant motor behavior, euphoria, and disinhibition) syndrome (p<0.05, family wise error cluster-level corrected).
CONCLUSION: Our study demonstrated that hyperactivity syndrome is related to hypoconnected default-mode network in Alzheimer's disease. This finding suggests that specific network alterations are associated with certain neuropsychiatric syndromes.

Entities:  

Keywords:  Alzheimer’s disease; Default-mode network; Functional magnetic resonance imaging; Hyperactivity; Medial prefrontal cortex; Neuropsychiatric symptoms

Year:  2020        PMID: 32571002     DOI: 10.30773/pi.2020.0009

Source DB:  PubMed          Journal:  Psychiatry Investig        ISSN: 1738-3684            Impact factor:   2.505


  6 in total

Review 1.  Psychosis in Alzheimer disease - mechanisms, genetics and therapeutic opportunities.

Authors:  Zahinoor Ismail; Byron Creese; Dag Aarsland; Helen C Kales; Constantine G Lyketsos; Robert A Sweet; Clive Ballard
Journal:  Nat Rev Neurol       Date:  2022-01-04       Impact factor: 44.711

2.  Episodic Memory Impairment Mediates the Loss of Awareness in Mild Cognitive Impairment.

Authors:  Geoffroy Gagliardi; Patrizia Vannini
Journal:  Front Aging Neurosci       Date:  2022-01-21       Impact factor: 5.750

3.  Alzheimer disease stages identification based on correlation transfer function system using resting-state functional magnetic resonance imaging.

Authors:  Doaa Mousa; Nourhan Zayed; Inas A Yassine
Journal:  PLoS One       Date:  2022-04-12       Impact factor: 3.240

4.  Locomotor Hyperactivity in the Early-Stage Alzheimer's Disease-like Pathology of APP/PS1 Mice: Associated with Impaired Polarization of Astrocyte Aquaporin 4.

Authors:  Tianqi Wang; Yan Chen; Ying Zou; Yingting Pang; Xiaoxin He; Yali Chen; Yun Liu; Weixi Feng; Yanli Zhang; Qian Li; Jingping Shi; Fengfei Ding; Charles Marshall; Junying Gao; Ming Xiao
Journal:  Aging Dis       Date:  2022-10-01       Impact factor: 9.968

Review 5.  The Impact of COVID-19 Infection and Enforced Prolonged Social Isolation on Neuropsychiatric Symptoms in Older Adults With and Without Dementia: A Review.

Authors:  Riccardo Manca; Matteo De Marco; Annalena Venneri
Journal:  Front Psychiatry       Date:  2020-10-22       Impact factor: 4.157

6.  Neural Correlates of Mild Behavioral Impairment: A Functional Brain Connectivity Study Using Resting-State Functional Magnetic Resonance Imaging.

Authors:  Teruyuki Matsuoka; Daisuke Ueno; Zahinoor Ismail; Ellen Rubinstein; Hiroyuki Uchida; Masaru Mimura; Jin Narumoto
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.